Biotech firm stocks rise on FDA vaccine head's exit
Source: SeekingAlpha
2026-03-09 09:40:31 ET
More on uniQure, Regenxbio, etc.
- Assessing Where Regenxbio Stands After FY25 Results
- REGENXBIO Inc. (RGNX) Q4 2025 Earnings Call Transcript
- uniQure: Worst Case Scenario Becomes Reality
- uniQure surges following departure of key FDA official
- Solid Biosciences announces $240 million private placement
Read the full article on Seeking Alpha
For further details see:
Biotech firm stocks rise on FDA vaccine head’s exit
Solid Biosciences Inc.
NASDAQ: SLDB
SLDB Trading
29.9% G/L:
$7.56 Last:
2,183,281 Volume:
$6.90 Open:
SLDB Latest News
March 08, 2026 07:30:50 pm
Solid Biosciences Shares Surge 14% Following $240 Million Private Placement Announcement
March 06, 2026 08:31:00 am
Solid Biosciences Announces Oversubscribed $240 Million Private Placement
SLDB Stock Data
$535,243,342
43,341,466
1.04%
23
N/A
Biotechnology & Life Sciences
Healthcare
US
Third FloorCharlestown
